762 



GENERAL INDEX 



Hematopoietic system, symptoms in, as- 

 sociated with typhoid disease, the 

 blood, hemoglobin and red cells, i, 

 350. 



hemorrhages, i, 352. 



leukocytes, i, 351. 



lymphatic glands, i, 352. 



spleen, i, 352. 



thymus, i, 352. 



viscosity, i, 352. 



Hemeralopia, ii, 765. 

 Hemianopsia, later, in hypophyseal dis- 

 ease, ii, 791. 



Hemihypertrophy, differentiated from 

 acromegaly, ii, 851. 



Hemiplegia, in thyroid disease, i, 353. 



Hemitetany, i, 594. 



Hemmende, i, 5. 



Hemoglobin, antecedents as hepatic in- 

 ternal secretion, ii, 479. 



breaking down of, iv, 558. 



rate of, methods of determining, 

 iv, 561. 



building up of, iv, 559. 



diet factors in, iv, 559. 



liver cell activity in, iv, 559. 

 Hemoglobin, character and function of, 



iii, 429. 



content of blood in normal and path- 

 ological subjects, iii, 430. 



estimation of, iii, 429, 431. 



in males and females during differ- 

 ent age periods, table of, iii, 430. 



Hemoglobin pigment metabolism, 

 breaking down of hemoglobin, regu- 

 latory function of liver in bile-pig- 

 ment metabolism, iv, 558. 



building up of hemoglobin, liver cell 

 activity and diet factors, iv, 559. 



methods of determining rate of 

 hemoglobin destruction, iv, 561. 



regulatory influence of spleen in 

 blood formation and destruction, iv, 

 562. 



Hemolytic anemia, iron metabolism in, 

 iv, 588. 



nitrogen partition in, iv, 584. 



purin metabolism in, iv, 580. 

 Hemolytic process, in blood destruction 



and regeneration, iv, 555. 

 Hemophilia, thyroid therapy in, i, 105. 



typical hereditary, disturbances in 

 mineral metabolism in, iii, 336. 



indications for blood transfusion in, 

 iii, 830. 



Hemorrhage in thyroid disease, i, 352. 



into the parathyroids, clinical tetany, 

 i, 568. 



Hemorrhage in thyroid disease, not 

 associated with tetany, i, 568. 



secondary to degenerative proc- 

 esses, i, 569. 



intravenous injection of fluids for, 

 iii, 790. 



metabolism in, iron, iv, 586. 



ocular, ii, 775. 



8ee also Ocular hemorrhage. 



of hypophysis cerebri, i, 772. 



of ovaries, ii, 606. 



of suprarenals, ii, 262. See also 

 Suprarenal hemorrhage. 



of the thymus, diffuse hematoma, ii, 

 382. 



hemorrhagic cysts, ii, 382. 



punctate hemorrhages, ii, 382. 



of the thyroid gland, i, 293. 



pulmonary, of autonomic origin, i, 

 334. 



vascoconstrictor action of epi- 

 nephrin in, i, 137. 



system, in thyroid disease, i, 353. 



uterine. See Uterine hemorrhage. 



vasoconstricting action of epinephrin 

 on, accessible, i, 135, 136. 



when from alimentary canal, i, 



136. 



from genito-urinary tract, i, 136. 



when from mouth and upper air 



passages, i, 135. 



when inaccessible, i, 137, 138. 



when from the kidney, i, 138. 



when internal, i, 138. 



when intestinal, i, 237. 



when pulmonary, i, 137. 



when renal, i, 137. 

 Hemorrhoids, vasoconstricting action 



of epinephrin on, i, 136. 

 Heparin, as hepatic internal secretion, 



ii, 681. 

 Hepatic disease, infantilism in, ii, 



877. 



leucin in urine in, iv, 476. 



tyrosin in urine in, iv, 476. 

 Hepatic function, fructose tolerance 



test, iv, 300. 



Hepatic internal secretion, antithrom- 

 bin as, ii, 680. 



blood serum proteins as, origin of 

 blood serum proteins, ii, 678. 



carbohydrate as, ii, 674. 



evidence of, from administration of 

 hepatic substance and derivatives, 

 cod liver oil, ii, 685. 



liver extracts, ii, 686. 

 liver substance, ii, 674. 



fibrinogen as, ii, 682. 



